Background: Long-term (tunneled cuffed) hemodialysis catheters are frequently used vascular access in renal failure patients. Catheter-related bloodstream infection (CRBSI) is a common complication of long-term hemodialysis catheters, with severe morbidities and high risk of mortality. Management of CRBSI by systemic antibiotics while keeping the catheter in place is not effective. Among the different modalities of CRBSI management are catheter removal (CR) and guidewire exchange (GE) of the catheter. The aim of this study was to compare the clinical outcome of CRBSI treated with two different strategies: GE vs CR with new catheter insertion 3 to 7 days later.
Long-term hemodialysis catheters are frequently used in renal failure patients until arteriovenous fistula maturation, or they may be used as a permanent access after all other access modalities have been exhausted. [1] [2] [3] Catheter-related bloodstream infection (CRBSI) is a common complication of long-term hemodialysis catheters, with severe morbidities and high risk of mortality. Among the different modalities of CRBSI management are catheter removal (CR) and guidewire exchange (GE) of the catheter. [4] [5] [6] [7] Studies comparing both treatment modalities are few, and none are randomized. The aim of this study was to compare the clinical outcome of CRBSI treated with two different strategies: GE vs CR with new catheter insertion 3 to 7 days later. Interim results of the first 100 cases of this work were previously published. 8 
METHODS
The study was performed at three tertiary referral centers in the Middle East (Prince Salman Hospital, Al Hada Military Hospital, and Saudi German Hospital). Our Institutional Review Board approved the study protocol, and written informed consent was obtained from all patients.
Study design. Patients with long-term hemodialysis CRBSI were prospectively randomized (by a sealed envelope randomization service 9 ) to undergo catheter replacement over guidewire 2 or 3 days after antibiotic therapy (GE group) or CR and new catheter insertion when the blood cultures with negative results were obtained (which is estimated to be after 3 to 7 days of CR). In the interim, dialysis was done through a short-term femoral catheter. All procedures were performed by vascular surgeons. Catheter infection-free survival time was evaluated. The technique of catheter replacement over guidewire is described in the Supplementary Methods (online only).
Inclusion criteria. All patients on regular hemodialysis using long-term catheters with suspected CRBSI with no other source of infection were included.
Exclusion criteria. Exclusion criteria are listed in Table I .
Management of CRBSI.
Infection was suspected when patients with a long-term hemodialysis catheter presented with fever, chills, and leukocytosis, with no identifiable alternative source of infection. Blood culture specimens from peripheral blood and the catheter were taken (first culture), then empirical antibiotics (vancomycin and gentamicin) were given during dialysis through the dialysis catheter. The diagnosis of CRBSI was considered if blood cultures from both the catheter and a peripheral blood specimen grew the same organism. All removed catheter tips were sent for culture (second culture). Systemic antibiotics for 3 weeks (according to culture sensitivity) were given to all patients. Blood cultures were repeated from a peripheral vein and the catheter 7 to 10 days after the course of antibiotics (third culture).
Definitions. Cure was considered if the patient became asymptomatic for at least 45 days after completion of the antibiotic course in addition to a negative result of the third blood culture. Treatment failure was defined as any bacteremia involving the original organism within 45 days after completion of the antibiotic course in addition to clinical manifestation of infection.
Indeterminate results were considered when unrelated death, CR for an unrelated reason within 45 days after completion of the antibiotic course, or infection with a different organism had occurred.
Data collection. Age, gender, diabetes mellitus, culture results, and complications associated with CRBSI were recorded for all patients.
Statistical analysis. Descriptive statistics was used to summarize the sample data. Catheter infection-free survival time was calculated. Hazard ratios and the associated 95% confidence intervals were computed. The catheter infection-free survival was analyzed using Kaplan-Meier analysis.
RESULTS
From December 2011 to November 2016, of 755 patients with CRBSI screened for possible inclusion, 678 patients met the inclusion criteria and were randomized into two groups, 339 patients in the GE group (113 patients from each center) and 339 patients in the CR group (113 patients from each center). Both groups were matched to each other in terms of mean age (56.7 vs 61.2 years), sex (61% vs 70.4% female), presence of diabetes mellitus (69.9% vs 69.6%), and organism type. The patients' demographic characteristics among the two groups were similar to those in the prevalent dialysis population. Table II outlines the demographics of the study population. Patients in the CR group had statistically significant longer median lengths of hospital stay (8.2 vs 1.4 days; P < .001). Recurrent CRBSI occurred in 1.8% of the GE group compared with 1.4% of the CR group (P ¼ .75). There was no statistically significant difference in mortality rate (1.3% vs 1.7%; P ¼ .29). There was no statistically significant difference in the catheter infection-free survival time for GE and CR groups (P ¼ .71; Fig 1; Tables III and IV) . Five patients with exit site infection and three patients with infected tunnel in the GE group were managed by changing the tunnel site during catheter exchange. In 45% of the GE group and in 46% of the CR group, antibiotics were tailored according to culture result. There were six patients in the CR group in whom access to the central veins failed (because of exhausted access sites); two were managed by transhepatic catheter and one by translumbar catheter, and three patients were shifted to peritoneal dialysis.
DISCUSSION
Treatment of CRBSI with antibiotics without CR is not usually effective. Only 22% to 32% of long-term hemodialysis catheters can be salvaged without CR. 4, 5, 10, 11 In addition, treatment of CRBSI with antibiotics alone carries the risk of serious systemic complications, including epidural abscess and endocarditis. 12 Several studies have reported that exchanging infected dialysis catheters over a guidewire, in combination with systemic antibiotics, results in successful resolution of the infection. However, none of these studies reported a concurrent control group for comparison of the outcomes. 6, 10, [12] [13] [14] [15] [16] [17] In our prospective randomized study, there was no statistically significant difference in catheter infection-free survival time whether the catheter was exchanged or removed. The GE strategy is a single, relatively simple procedure, with no interruption of the outpatient hemodialysis schedule. Moreover, the catheter exchange strategy avoids complications of new venipuncture, saves veins for future access, and decreases the cost. In contrast, the CR strategy involves two separate procedures, one (at least) femoral dialysis catheter placement, and longer hospital stay. Moreover, CR carries the risk of losing a potential vascular access site, and we reported such a critical situation in six Graph shows the Kaplan-Meier survival analysis for infection-free survival of the replacement catheter in patients whose dialysis catheter was replaced with one of two strategies: guidewire exchange (GE), replacement over a guidewire 2 to 3 days after antibiotic therapy; and catheter removal (CR), followed by insertion of a new catheter 3 to 10 days later (P ¼ .71). patients. The GE strategy is successful even in patients having tunnel or exit site infection, provided the tunnel site is changed during catheter exchange. However, we do not recommend GE in patients presenting with severe infection (septic shock or metastatic infection) as the delay in CR carries a great risk of mortality, 18, 19 so the GE strategy is not for routine use but for selective use. The protocol used for CRBSI management at our institutions is highly successful, with CR in patients presenting with severe infection and GE in all other patients, as illustrated in Fig 2. Tanriover et al 14 reported that patients with hypoalbuminemia (serum albumin concentration <3.5 g/dL) showed a higher hazard of a second episode of CRBSI than patients with a normal serum albumin concentration. However, in our report, we did not find a relationship between CRBSI and serum albumin level. In our centers, 65% of new hemodialysis patients and 41% of prevalent hemodialysis patients are using a dialysis catheter, rates that are substantially higher than those observed in the American and European hemodialysis patients, probably because of the high incidence of diabetes (69.9) with subsequent lack of suitable vessels for arteriovenous fistula creation.
CONCLUSIONS
Our study did not demonstrate a difference in the clinical outcome of CRBSI treated with GE or CR with new catheter insertion 3 to 7 days later. However, guidewire catheter exchange saves veins for future access, reduces the cost and number of procedures, and avoids complications of new venipuncture. 
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